Robert A. Krance

Hematology | Oncology

6621 Fannin St Fl 8
Houston, TX 77030

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia Patients Have Dismal Outcomes Irrespective of Allogeneic Hematopoietic Stem Cell Transplant: A Single-Center Experience.

Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia Patients Have Dismal Outcomes Irrespective of Allogeneic Hematopoietic Stem Cell Transplant: A Single-Center Experience.

Journal: Cancers

Published: October 02, 2025

Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 years.

Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 years.

Journal: Blood advances

Published: March 24, 2025

Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors.

Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors.

Journal: Pediatric blood & cancer

Published: November 21, 2024

Imlifidase Utilization in Glanzmann Thrombasthenia With Anti-GPIIb/IIIa and Anti-HLA Alloimmunization and Severe Platelet Refractoriness Following Hematopoietic Stem Cell Transplant.

Imlifidase Utilization in Glanzmann Thrombasthenia With Anti-GPIIb/IIIa and Anti-HLA Alloimmunization and Severe Platelet Refractoriness Following Hematopoietic Stem Cell Transplant.

Journal: Pediatric blood & cancer

Published: April 09, 2024

Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab.

Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab.

Journal: Pediatric hematology and oncology

Published: December 22, 2023

Should posttransplant cyclophosphamide be considered standard of care for pediatric transplantation of acute leukemia?

Should posttransplant cyclophosphamide be considered standard of care for pediatric transplantation of acute leukemia?

Journal: Hematology. American Society of Hematology. Education Program

Published: December 09, 2023

Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia.

Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia.

Journal: Transplantation and cellular therapy

Published: August 28, 2023

Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors.

Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors.

Journal: Cytotherapy

Published: August 13, 2023

Prospective assessment of risk biomarkers of sinusoidal obstruction syndrome after hematopoietic cell transplantation.

Prospective assessment of risk biomarkers of sinusoidal obstruction syndrome after hematopoietic cell transplantation.

Journal: JCI insight

Published: December 19, 2022

Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival.

Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival.

Journal: Blood advances

Published: September 27, 2022

Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting.

Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 03, 2022

Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.

Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.

Journal: Journal of clinical immunology

Published: May 02, 2022

Showing 1-12 of 71

Last Updated: 09/26/2026